Antibiotic Prophylaxis in Reduction Mammaplasty: A National Survey

Background Although there is limited evidence for regulating the use of prophylactic antibiotics in reduction mammaplasty, many plastic surgeons prescribe them, even in the postoperative period. This study aimed to conduct a national survey to investigate the antibiotic prophylaxis protocols followed by Brazilian plastic surgeons in reduction mammaplasty. Methods An anonymous survey comprising 19 questions was sent to all 4864 active members of the Brazilian Society of Plastic Surgery (SBCP). The surgeons electronically received the invitation to participate in the survey and the link to fill out the electronic form. Results In total, 859 surgeons (17.7%) responded. Most respondents (77.8%) were men and aged 35–55 years (61.5%); 58.6% of them had 10–29 years of specialty training. Only a minor proportion of the respondents (0.5%) reported not prescribing antibiotics at any time (95% confidence interval [CI]: 0.0–0.9), 9.9% (95% CI: 7.9–11.9) prescribed them only preoperatively, and 14.6% (95% CI: 12.2–16.9) prescribed continued antibiotic use for 24 h. The majority of the respondents (75.1%; 95% CI: 72.1–77.9) prescribed antibiotics for additional days after discharge. There were significant associations between antibiotic prescription and the surgeons’ age group ( p = 0.015), time since graduation ( p